Japan-based drugs company Takeda Pharmaceutical rebrands venturing unit Takeda Ventures.
Japan-based drugs company Takeda Pharmaceutical has this month rebranded its US-based corporate venturing group as part of a wider shift at the company to develop its global operations.
Graeme Martin, president of California-based Takeda Research Investment (TRI) since 2003, said the change to become Takeda Ventures "heralds a very clear statement that Takeda is a global pharmaceutical company".
TRI was formed in 2001 as Takeda’s first overseas intelligence hub for its research division that otherwise would have remained isolated geographically,…
